Literature DB >> 21673298

Changing concepts of Alzheimer disease.

Guy M McKhann1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21673298     DOI： 10.1001/jama.2011.810

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  36 in total

1.  Biomarkers of neurodegeneration - not only Alzheimer's disease and not only cerebrospinal fluid: a guest-editor's introduction.

Authors:  Piotr Lewczuk
Journal:  J Neural Transm (Vienna)       Date:  2012-07       Impact factor: 3.575

Review 2.  Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.

Authors:  Fernando Calahorro; Manuel Ruiz-Rubio
Journal:  Invert Neurosci       Date:  2011-11-08

3.  Intranetwork and internetwork connectivity in patients with Alzheimer disease and the association with cerebrospinal fluid biomarker levels.

Authors:  Marina Weiler; Brunno Machado de Campos; Camila Vieira de Ligo Teixeira; Raphael Fernandes Casseb; Ana Flávia Mac Knight Carletti-Cassani; Jéssica Elias Vicentini; Thamires Naela Cardoso Magalhães; Leda Leme Talib; Orestes Vicente Forlenza; Marcio Luiz Figueredo Balthazar
Journal:  J Psychiatry Neurosci       Date:  2017-11       Impact factor: 6.186

Review 4.  Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities.

Authors:  Abhay P Sagare; Rashid Deane; Berislav V Zlokovic
Journal:  Pharmacol Ther       Date:  2012-07-20       Impact factor: 12.310

5.  Differences and the relationship in default mode network intrinsic activity and functional connectivity in mild Alzheimer's disease and amnestic mild cognitive impairment.

Authors:  Marina Weiler; Camila Vieira Ligo Teixeira; Mateus Henrique Nogueira; Brunno Machado de Campos; Benito Pereira Damasceno; Fernando Cendes; Marcio Luiz Figueredo Balthazar
Journal:  Brain Connect       Date:  2014-09-19

6.  Searching biomarkers for mental disorders-lessons from Alzheimer's disease.

Authors:  W Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-10       Impact factor: 5.270

7.  Subtle changes in daily functioning predict conversion from normal to mild cognitive impairment or dementia: an analysis of the NACC database.

Authors:  Milap A Nowrangi; Paul B Rosenberg; Jeannie-Marie S Leoutsakos
Journal:  Int Psychogeriatr       Date:  2016-08-08       Impact factor: 3.878

8.  CSF soluble TREM2 as a measure of immune response along the Alzheimer's disease continuum.

Authors:  Boris-Stephan Rauchmann; Thomas Schneider-Axmann; Panagiotis Alexopoulos; Robert Perneczky
Journal:  Neurobiol Aging       Date:  2018-10-25       Impact factor: 4.673

9.  Classification of mild cognitive impairment and Alzheimer disease using model-based MR and magnetization transfer imaging.

Authors:  R Wiest; Y Burren; M Hauf; G Schroth; J Pruessner; M Zbinden; K Cattapan-Ludewig; C Kiefer
Journal:  AJNR Am J Neuroradiol       Date:  2012-10-11       Impact factor: 3.825

10.  Mapping CSF biomarker profiles onto NIA-AA guidelines for Alzheimer's disease.

Authors:  Panagiotis Alexopoulos; Jennifer Roesler; Nathalie Thierjung; Lukas Werle; Dorothea Buck; Igor Yakushev; Lena Gleixner; Simone Kagerbauer; Marion Ortner; Timo Grimmer; Hubert Kübler; Jan Martin; Nikolaos Laskaris; Alexander Kurz; Robert Perneczky
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-08-08       Impact factor: 5.270
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.